Skip to main content

Peer Review reports

From: Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China

Original Submission
20 Dec 2020 Submitted Original manuscript
28 Jan 2021 Reviewed Reviewer Report - Nontuthuko Excellent Maningi
16 Feb 2021 Reviewed Reviewer Report
7 Apr 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 2
7 Apr 2021 Submitted Manuscript version 2
13 Apr 2021 Reviewed Reviewer Report
14 Apr 2021 Reviewed Reviewer Report - Nontuthuko Excellent Maningi
30 Apr 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 3
30 Apr 2021 Submitted Manuscript version 3
7 Jun 2021 Reviewed Reviewer Report
20 Jun 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 4
20 Jun 2021 Submitted Manuscript version 4
30 Aug 2021 Reviewed Reviewer Report
10 Sep 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 5
10 Sep 2021 Submitted Manuscript version 5
13 Sep 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 6
13 Sep 2021 Submitted Manuscript version 6
14 Sep 2021 Author responded Author comments - Mu-tong Fang
Resubmission - Version 7
14 Sep 2021 Submitted Manuscript version 7
Publishing
16 Sep 2021 Editorially accepted
28 Sep 2021 Article published 10.1186/s12879-021-06705-4

You can find further information about peer review here.

Back to article page